Medication info
Telmisartan/Amlodipine Tablets 40/5 mg

Telmisartan/Amlodipine Tablets 40/5 mg

Prescription medicationOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Independence Bio Pharmaceuticals Co., Ltd.
Appearance
White and light blue biconvex oval double tablet
Packaging
30 tablets/box [(10 tablets/PTP*3)], 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201906142 · Approved 2019.08.29 · Insurance code 057700370

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). It is recommended that the doses of the individual components (telmisartan or amlodipine) be adjusted before starting this medicine. However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: Although the usual amlodipine dosage is recommended for older adults, caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution’). In older adults aged 75 years and over, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Independence Bio Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

Used as an additional treatment option for patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of telmisartan or amlodipine.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). It is recommended that the doses of the individual components (telmisartan or amlodipine) be adjusted before starting this medicine. However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: Although the usual amlodipine dosage is recommended for older adults, caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution’). In older adults aged 75 years and over, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

○ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication may cause severe harm to the fetus during pregnancy, especially in the second and third trimesters; hence, it should not be taken by women who are pregnant or may become pregnant. Patients with an allergy to the active ingredient or similar components, severe liver dysfunction or obstructive biliary disease, severe hypotension, patients in cardiogenic shock, and unstable heart failure after acute myocardial infarction should not take this medication. Patients with primary aldosteronism, aortic stenosis, mitral stenosis, obstructive hypertrophic cardiomyopathy, liver dysfunction, gastrointestinal diseases, renal artery hypertension, patients requiring dialysis, and the elderly should use this medication with caution. Dizziness and peripheral edema are common side effects of this medication, and occasionally fainting or cardiac-related adverse reactions can occur, so any abnormal symptoms should be reported to a healthcare professional immediately. During pregnancy, the use of this medication may cause serious side effects such as decreased fetal renal function, delayed skull formation, and hypotension; if pregnancy is confirmed, the medication should be stopped immediately and alternative treatment should be sought. Breastfeeding women should avoid taking this medication as its ingredients may be passed into breast milk. This medication may interact with other antihypertensives or specific medications; therefore, patients should inform their healthcare provider of any concurrent medications and regular blood pressure and blood tests should be performed to monitor their condition. Due to the risk of hypotension, patients with inadequate fluid or salt intake should be particularly cautious, and if hypotensive symptoms develop, they should lie down and rest and may require fluid treatment. While taking this medication, caution is needed when driving or operating hazardous machinery due to potential dizziness or drowsiness. In case of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur, and immediate medical attention should be sought. This medication is not recommended for children due to insufficiently established safety and efficacy.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 102 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • sensory impairment
  • taste disturbances
  • tremors
  • extrapyramidal disorder
  • muscle hypertonia
  • visual impairment
  • double vision
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gum hypertrophy
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • hepatic dysfunction
  • liver disease
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • acute renal failure
  • disorders of urination
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a special container that does not allow light to enter. Additionally, it is important to store it at room temperature between 1 degree and 30 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

White and light blue biconvex oval double tablet

Package unit

30 tablets/box [(10 tablets/PTP*3)], 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.